Background Hemodynamic instability and myocardial dysfunction are major factors
preventing the transplantation of hearts from organ donors after brain death. Intravenous …

Background: Low levels of the active thyroid hormone triiodothyronine (T3) in cardiac
patients are associated with worse outcomes. The aim of this analysis was to assess if T3 …

Thyroid hormone levels are reduced in cardiovascular diseases and this phenomenon is
associated with worse outcomes. It is unclear whether the changes in thyroid hormone …

The proposed donor heart selection guidelines provide evidence-based and expert-
consensus recommendations for the selection of donor hearts following brain death. These …

This clinical practice guideline is intended for use in the care of both neurologically
deceased adult and pediatric potential organ donors. We based our recommendations on …

BACKGROUND Donor thyroid hormone (TH) supplementation therapy is widely used.
Recent reports suggested an increased risk of graft dysfunction in heart transplant (HTx) …

Rationale Brain‐dead (BD) organ donors frequently exhibit hemodynamic instability and/or
reversible cardiac dysfunction. Retrospective studies have suggested that thyroid hormone …

Rationale: Brain death (BD) precipitates cardiac dysfunction impairing the ability to
transplant hearts from eligible organ donors. Retrospective studies have suggested that …

Objective Heart transplantation (HT) is uniquely associated with the potential impact of
thyroid hormone therapy at three intersecting levels—donor, operation, and recipient. We …

Solid organ transplantation has become a mainstay in the contemporary management of
end-stage organ failures fueled by advances in immunosuppression, intensive care and …